SCHEMBL13148100

SCHEMBL13148100

O=C(Nc1cc(F)ccc1N1CCCCC1)c1ccc([N+](=O)[O-])o1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 8/20 0.73
▸ KMT2A Q03164 8/20 0.71
▸ MEN1 O00255 4/20 0.71
▸ GAA P10253 2/20 0.71
▸ POLB P06746 3/20 0.71
▸ MITF O75030 8/20 0.67
▸ RAB9A P51151 5/20 0.67
▸ NPC1 O15118 4/20 0.67
▸ ALDH1A1 P00352 4/20 0.67
▸ MAPT P10636 3/20 0.67
▸ SMN1; SMN2 Q16637 3/20 0.67
▸ MAPK1 P28482 2/20 0.67
▸ NPSR1 Q6W5P4 1/20 0.67
▸ HSP90AA1 P07900 1/20 0.60
▸ LMNA P02545 2/20 0.58
▸ ADRB2 P07550 1/20 0.56
▸ HTT P42858 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13148021 0.87 CSF1R (0.73) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL5093277 0.84 CSF1R (1.00) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL13148038 0.84 CSF1R (1.00) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL15503733 0.83 KMT2A (1.00) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL13148062 0.75 CSF1R (1.00) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL18499225 0.74 KMT2A (0.85) CSF1RKMT2AMEN1GAAPOLB
SCHEMBL14392607 0.74 CSF1R (0.74) CSF1RGAANPC1ALDH1A1MAPT
SCHEMBL13148057 0.74 CSF1R (1.00) CSF1RKMT2AGAAPOLBMITF
SCHEMBL20198520 0.73 NPSR1 (0.72) KMT2AMEN1GAAPOLBALDH1A1
SCHEMBL13148031 0.73 CSF1R (1.00) CSF1RKMT2AGAAPOLBMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
Send feedback